Plinabulin Ameliorates Chemotherapy-Induced Neutropenia: Mechanistic Insights
Guanine Nucleotide Exchange Factor-H1 Signaling is Critical for Induction of Anti-Tumor Immunity Induced by Microtubule-Depolymerizing Drugs
Plinabulin is a Small Molecule Clinical Stage Immune-Oncology Agent for NSCLC
Plinabulin, a Novel Small Molecule That Ameliorates Chemotherapy-Induced Neutropenia, is Administered on the Same Day of Chemotherapy and Has Anticancer Efficacy
Plinabulin: Evidence for an Immune-Mediated Mechanism of Action
© 2020 BeyondSpring Inc. All rights reserved.